# Effects of Prazosin on the Attention-Enhancing Effects of Nicotine

> **NCT03416569** · NA · WITHDRAWN · sponsor: **University of Maryland, Baltimore**

## Conditions studied

- no Condition, Basic Science

## Interventions

- **DRUG:** Placebo
- **DRUG:** Nicotine
- **DRUG:** Prazosin
- **DRUG:** Nicotine + Prazosin

## Key facts

- **NCT ID:** NCT03416569
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-03
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unanticipated staff changes are preventing completion within funding period.
- **Last updated:** 2019-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03416569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03416569, "Effects of Prazosin on the Attention-Enhancing Effects of Nicotine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03416569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*